Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2020 February Health Innovation More precise radiation treatment thanks to new scanning equipment at Bordet institute Read more
2020 February Fundraising Flemish cancer foundation hands out 19 million in grants and subsidies Read more
2020 February Science Bariatric surgery linked to significant reduction of VTE-risk in obese patients Read more
2020 February Medical Research Bruising after a blood draw: when do symptoms turn into alarm signals? Read more
Top
